Heterophoria. Heterophoria
Conditions
Interventions
Intervention 1: Intervention group: Atropine drops with a dose of 0.025% are poured into each eye every night for a week. In order to prepare a dose of 0.025%, one milliliter of 0.5% (produced by Sina
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: 18 to 25 years old best correction visual acuity 20/20 stereo acuity maximum 40 second anisometropia lower than 2 diopters
Exclusion criteria
Exclusion criteria: history of ocular surgery history of ocular symptoms with near work history of transient blurred vision or diplopia history of strabismus and amblyopia history of ocular pathology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accommodation indicators. Timepoint: One week after dripping of 0.025% atropine. Method of measurement: Near E chart, Minus & positive.;Vergence indicators. Timepoint: One week after dripping of 0.025% atropine. Method of measurement: positive and negative fusional vergence, near point of vergence, cover test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Refractive error. Timepoint: One week after dripping of 0.025% atropine drops. Method of measurement: Retinoscopy method and autorefractometer.;Visual acuity. Timepoint: One week after dripping of 0.025% atropine drops. Method of measurement: Log MAR chart at 6 m and 40 cm. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Mirzajani
Iran University of Medical Sciences
Outcome results
None listed